Clinical trial
Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
NCT00275613 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00275613 |
|---|---|
| Title | Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis |
| Official title | Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Glomerulonephritis, Membranoproliferative |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 10 |
| Start date | Nov 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jan 12, 2006 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: